A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

NCT04997239 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Influenza

Interventions

BIOLOGICAL: Two doses of quadrivalent influenza vaccine
BIOLOGICAL: One dose of quadrivalent influenza vaccine

Sponsor

Sinovac Biotech Co., Ltd